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Introduction
Monitoring the clinical evolving stages and cardiopul-
monary sequelae, in terms of organ injury and functional 
response, of elderly individuals infected with SARS-CoV-2 
is of utmost importance for our times, placing gas exchange 
and functional capacity evaluation in the forefront of the 
clinical decision-making process, i.e., for staging, prognos-
tication and for establishing the most appropriate therapeu-
tic strategies tailored for the elderly population that is the 
most impacted by this pandemic. From a geriatric point of 
view, the assessment of clinical and functional outcomes, 
such as mobility of the elderly individuals, their daily energy 
expenditure and other indices of physical function and qual-
ity of life coupled with the determination of the maximal 
aerobic capacity, one of the most important predictors of 
independence, offers a multidimensional evaluation-tool 
useful for monitoring the COVID-19 effects in the elderly 
population. Historically, cardiopulmonary exercise test 
(CPET) evaluation has multifold goals, such as providing a 
thorough and objective definition of physical limitation and 
garnering information on how interventions may impact the 
limiting steps in the symptoms cascade and along the natural 
course of disease.
This information and the step-by-step analyses on dif-
ferential diagnosis of organ-driven origin of symptoms are 
generally accomplished by performing preliminary static 
pulmonary function tests (spirometry) and alveolar gas dif-
fusion for carbon monoxide (DLco) evaluation.
Most of the evidence so far accumulating on COVID-
19 patients suggests that: (a) the lung organ injury is sus-
tained, persistent, expectedly irreversible in many patients 
[1] and is predicted to become the main clinical issue on 
the long term; (b) cardiovascular comorbidities are highly 
represented, and a very frequent background for associated 
complications; (c) myocarditis or acute coronary syndrome 
may complicate the acute phase. Irrespective of documented 
myocarditis, the values of the convectional biomarkers of 
myocardial injury, especially cardiac troponins, may con-
siderably increase. These COVID-19 complications may 
occur in previously asymptomatic or symptomatic subjects, 
without or with lung and/or cardiac pre-existing diseases. 
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Specifically, subjects with recognized left/right heart dis-
ease, ischemic heart disease, pulmonary hypertension, lung 
fibrosis, pulmonary embolism, venous thromboembolism, 
diffusive impairment, restrictive lung function pattern and 
effort-related  SpO2 desaturation need to be accounted before 
starting exercise testing. It is important to note that the detri-
mental effects of aging on the cardiovascular and pulmonary 
systems are exacerbated by the COVID-19 sequels.
Based on previous long-term observations of patients 
with COVID-19, those needing intensive care at admission 
displayed a reduction in lung function spirometry FVC, TLC 
and 23.7% decline in DLco compared to patients who did not 
need intensive care unit (ICU) admission [2].
Based on this evidence and assuming that at least one 
out three of elderly individuals with COVID-19 has been 
admitted to the ICU, the application and the derived infor-
mation by lung function test, gas exchange and CPET will 
be foundational and straightforward in progressive evalu-
ation. Moving forward from the acute clinical scenarios, 
the determination of COVID-19-induced maximal aerobic 
capacity limitations, coupled with the determination of 
potential functional and physical impairments are impera-
tive before starting specific rehabilitation strategies in the 
elderly individuals with long term cardiovascular and pul-
monary impairments.
Clinical phases treatments of COVID‑19
Early infection, 1st phase
The virus is present in the upper airways. An initial immune 
response develops, with production of antibodies and prim-
ing of cytotoxic lymphocytes, which is then accompanied 
by a sustained inflammatory reaction. In this phase, usual 
treatments are based on drugs with mixed antiviral and anti-
inflammatory activity and antibacterial drug with minimal 
anti-viral action. Even though the physical function of 
the elderly patients in this phase of the COVID-19 is not 
extremely compromised, our recommendation is to under-
take the protocols for the CPET after the natural ending of 
the infection, when patients muscle weakness and fatigue are 
not exacerbated by the disuses.
Pulmonary‑proliferative 2nd phase
In this phase, the virus migrates into the lower respiratory 
tract (i.e., lungs). This phase can be characterized by low 
peripheral oxygen saturation  (SpO2 < 95%). Endothelial 
and initial cardiac damage are also possible. At this stage, 
hospitalization in semi-intensive care units may be neces-
sary for administration of standard oxygen therapy. Patients 
who fail to ameliorate with standard oxygen therapy may be 
relocated to advanced oxygen and mechanical ventilation. 
Frequently, frail elderly patients may also have increased 
work of breathing and challenging breathing, which could 
be managed via non-invasive ventilation such as continuous 
positive airway pressure (CPAP) or bi-level positive airway 
pressure (BiPAP). Patients with persistent hypoxic failure 
usually undergo prone ventilation and, when the respiratory 
failure is severe, intubation and forced mechanical venti-
lation. Due to the severity of the pulmonary, cardiovascu-
lar dysfunction and disuses-induced muscle weakness no 
maximal exercise tests are recommended in this phase of 
the COVID-19 infection.
Pulmonary‑hyper‑inflammatory 3rd phase
This phase is characterized by systemic symptoms with 
multi-organ involvement and sometimes cardiac failure. 
Specific treatments in this phase are needed, including cor-
ticosteroids, human immunoglobulins, inhibitors of IL-6, 
IL-2, and JAK2 receptor. This phase typically encompasses 
hospitalization in ICU or respiratory ICU. Similar to the 
2nd phase, as lung dysfunction progresses, oxygen-therapy 
shall be increased until non-invasive mechanical ventilation 
is required. Due to the severity of the pulmonary, cardiovas-
cular dysfunction and disuses-induced muscle weakness no 
maximal exercise tests are recommended in this phase of the 
COVID-19 infection.
Vasculitic‑thrombotic 4th phase
This phase is characterized by massive endothelial impair-
ment, pro-thrombotic and hypercoagulable state, with fre-
quently associated pulmonary thrombosis and hypertension. 
Specific drug treatments in this phase encompass antico-
agulants (especially heparin) or phosphodiesterase inhibi-
tors releasing nitric oxide for managing pulmonary hyper-
tension. Due to the severity of the pulmonary dysfunction 
and disuses-induced muscle weakness, no maximal exercise 
tests are recommended for elderly patients this phase of the 
COVID-19 infection.
Specific exercise testing procedure
Due to involvement of pulmonary and cardiovascular sys-
tems during exercise testing, and as previously discussed, the 
impact of both aging and COVID-19 on pulmonary and car-
diovascular function, specific attention needs to be focused 
on respiratory and cardiovascular alert signs before and 
during exercise testing. It is important to note that the indi-
rect effect of social distancing and the clinical procedures 
(bed confinement) adopted for the elderly individuals with 
COVID-19 severely impacted the level of leisure physical 
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activity, exacerbating the skeletal muscle weakness and 
fatigue due to the disuse of locomotor muscles. This severe 
peripheral limitation is a limit that need to be accounted 
for the precise assessment of pulmonary of cardiovascular 
limitations during high intensity exercise. Therefore, before 
starting a maximal aerobic test such as CPET, two aspects 
need to be accounted:
a) In case the elderly individual presents a reduced level of 
physical activity, muscle weakness and fatigue we rec-
ommend postponing the CPET scheduling after geriatric 
and physiatrist assessment.
b) Low-level activity (e.g., plane walking or cycling for 
at least 5  min) is recommended, with continuously 
monitoring  SpO2 and recording electrocardiogram 
(ECG) before and after the test (or via telemetry). If 
effort-related desaturation occurs, detected  (SpO2 reduc-
tion ≥ 4%), and abnormal ECG changes (arrhythmic 
alteration such as atrioventricular block, sinus tachy-
cardia or ST-segment elevation) are detected, we rec-
ommend postponing the CPET and scheduling after 
cardiological or pulmonary assessment. The detailed 
respiratory and cardiovascular alert-signs before and 
during exercise testing for elderly  individuals are 
described in Fig. 1.
Fig. 1  Respiratory and cardiovascular alert signs in elderly population in the era of COVID-19. CPET: cardio-pulmonary exercise test;  SpO2: 
blood oxygen saturation, b/min: beats for minute, ECG: electrocardiography
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Exercise testing protocols for elderly 
individuals in the era of COVID‑19
Elderly population, especially is case of a sedentary life-
style, as well as for elderly individuals with moderate to 
severe cardiovascular or pulmonary diseases, moderate 
testing protocols should be considered. Indeed, the per-
sonalization of the exercise protocol for estimating the 
individual perceived functional capacity shall be carried 
out by means of an activity-specific questionnaire, in con-
junction with other baseline variables such as the deter-
mination of the sensor-based daily energy expenditure or 
cumulated walking time. Subjects should be interview via 
E-visit and telehealth for maintaining social distancing 
[3]. Motorized treadmill or a stationary cycle ergometer, 
among the vast spectrum of exercise modalities, are typi-
cally used for assessment of exercise capacity. However, 
cycle ergometry is preferred in elderly subjects because 
the ambulation instability may alter the results of the exer-
cise test. Exercise tests with large increments of work rate 
have weaker correlation with oxygen uptake  (VO2). There-
fore, the Naughton [4] protocol, which only involve mod-
est increases in work rate per stage, are recommended in 
COVID-19 elderly individuals. Moreover, intervals of 10 
to 60 s between increments in work rate are typically rec-
ommended for ramp protocols. As previously mentioned, 
the exercise should be tailored to the individual capacity 
and to yield a fatigue-limited exercise duration of 8 to 
12 min. The choice of treadmill exercise testing should be 
limited to COVID-19 elderly individuals with a very active 
lifestyle and no evidence of cardiovascular and pulmonary 
complications at rest. In this case, minimal or no handrail 
support should be encouraged, because this will otherwise 
reduce the work performed at any given level and alters the 
relationship between  VO2 and work rate.
Data acquirement during exercise
Heart rate, ECG, blood pressure and blood oxygen satu-
ration should be monitored continuously throughout the 
exercise test (Fig. 1). Moreover, perceived exertion and 
symptoms (dyspnea/angina) should be recorded at regular 
intervals (60 s) throughout the exercise test. Dyspnea or 
angina should be recorded at symptoms onset with 1-to-4 
scales. Due to the potential consequences of COVID-19 
on cardiac function, the assessment of ECG and potential 
altered responses such as arrhythmias, ST-segment shifts 
are necessary. It is also important to screen the appearance 
of the elderly subject for identifying potential changes of 
alertness, coordination, and responsiveness during exer-
cise. Termination criteria for exercise testing include 
subject’s request, moderate to severe dyspnea or angina, 
specific ECG changes (arrhythmias or ST-segment shifts), 
abnormal blood pressure responses and decrease in blood 
oxygen saturation > 4%. Monitoring the heart rate, blood 
pressure, ECG and blood oxygen saturation during recov-
ery is important because abnormalities occurring during 
the post-exercise period provide valuable diagnostic and 
prognostic information.
Emergency procedures
Although exercise testing (maximal and submaximal) is a 
safe procedure, even in the oldest-old and frail population, 
specific attention needs to be focused on potential COVID-
19 sequels on cardiovascular and pulmonary systems. All 
testing facilities (clinical and subclinical) must have equip-
ment, drugs, and personnel trained to deliver appropriate 
emergency care as previously reported in the joint position 
papers of the AHA and the ACSM [5]. A specific plan for 
rapid accessibility should be clearly defined when the exten-
sive equipment cart is located in an area other than the test-
ing area. A defibrillator should be always present in every 
exercise laboratory, and its function should be monitored on 
a daily basis and recorded in a log for quality control.
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